Literature DB >> 12029414

Hyperbaric oxygen attenuates lipopolysaccharide-induced acute lung injury.

M-Y Lu1, B-H Kang, F-J Wan, C-S Chen, K-L Huang.   

Abstract

OBJECTIVES: To study the effect of hyperbaric oxygen therapy in alleviating acute lung injury induced by lipopolysaccharide (LPS) in rats. DESIGN AND
INTERVENTIONS: The rats received an intraperitoneal injection of LPS (15 mg/kg). Animals were either breathing air at 1 ATA or subjected to hyperbaric oxygen (HBO(2)) therapy. The HBO(2) therapy was carried out in a hyperbaric chamber at a pressure of 3 ATA for 90 min. In another two groups, LPS-treated rats also received intraperitoneal injection of N(omega)-nitro-L-arginine (LNAME, 25 mg/kg) or L-N(6)-(iminoethyl)lysine (LNIL, 10 ml/kg). Another two groups of LPS-treated rats were subjected to HBO(2) exposure after the injection of L-NAME or L-NIL.
MEASUREMENTS AND MAIN RESULTS: The bronchoalveolar lavage (BAL) was done into the left lung at 7.5 h after intraperitoneal injection of LPS. Parts of the right lung were excised for myeloperoxidase measurement, whereas the rest was collected for wet/dry ratio determination. LPS significantly increased the nitrite/nitrate (NO(x)(-)) concentration (34.4+/-15.7 vs 4.5+/-3.1 microM), LDH activity (66+/-17 vs 46+/-15 mAbs/min), and protein concentration (373+/-119 vs 180+/-90 mg/l) in the BAL fluid. Treatment with HBO(2) immediately after the injection of LPS enhanced the increase of NO(x)(-) production, but reduced the LDH and protein in BAL fluid to the control levels. Pretreatment with either L-NAME or L-NIL abolished the increase of NO(x)(-) in the BAL fluid and further elevated the LDH level and protein concentration.
CONCLUSION: Our results suggested that HBO(2) alleviates the LPS-induced acute lung injury, which may be related to the enhancement of nitric oxide production.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029414     DOI: 10.1007/s00134-002-1262-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  7 in total

1.  Hyperbaric oxygen and sepsis: time to recognize.

Authors:  Claus-Martin Muth; Peter Radermacher; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2005-07-21       Impact factor: 17.440

2.  Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.

Authors:  Alaa N A Fahmi; George S G Shehatou; Abdelhadi M Shebl; Hatem A Salem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-28       Impact factor: 3.000

3.  Effects of hyperbaric oxygen treatment on liver functions, oxidative status and histology in septic rats.

Authors:  Sukru Oter; Mustafa Edremitlioglu; Ahmet Korkmaz; Omer Coskun; Dilek Kilic; Ucler Kisa; Hakan Yaren; Hayati Bilgic
Journal:  Intensive Care Med       Date:  2005-07-21       Impact factor: 17.440

4.  The Role of Duration of Hyperbaric Oxygen Therapy on Lung Injury: An Experimental Study Lung Injury and Hyperbaric Oxygen Therapy.

Authors:  Menduh Oruç; Bennur Esen; Maşuk Taylan; Yusuf Nergis; Atalay Şahin
Journal:  Turk Thorac J       Date:  2018-04-01

5.  Deconvolution of RNA-Seq Analysis of Hyperbaric Oxygen-Treated Mice Lungs Reveals Mesenchymal Cell Subtype Changes.

Authors:  Yuan Yuan; Yilu Zhou; Yali Li; Charlotte Hill; Rob M Ewing; Mark G Jones; Donna E Davies; Zhenglin Jiang; Yihua Wang
Journal:  Int J Mol Sci       Date:  2020-02-18       Impact factor: 5.923

6.  Attenuation of acute lung inflammation and injury by whole body cooling in a rat heatstroke model.

Authors:  Hsi-Hsing Yang; Ching-Ping Chang; Ruei-Tang Cheng; Mao-Tsun Lin
Journal:  J Biomed Biotechnol       Date:  2009-12-15

7.  Evaluation of the inflammatory response in a two-hit acute lung injury model using [18F]FDG microPET.

Authors:  Guang-Ju Zhou; Shou-Yin Jiang; Mao Zhang; Jian-Xin Gan; Guan-Yu Jiang
Journal:  Exp Ther Med       Date:  2013-08-13       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.